StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
4563
This month
89
This week
24
This year
478
Today
4
Yesterday
12
Publishing Date
2024 - 04 - 24
8
2024 - 04 - 23
6
2024 - 04 - 22
6
2024 - 04 - 19
6
2024 - 04 - 17
6
2024 - 04 - 10
7
2024 - 04 - 09
5
2024 - 04 - 08
5
2024 - 04 - 05
7
2024 - 04 - 03
5
2024 - 04 - 02
5
2024 - 03 - 28
5
2024 - 03 - 27
9
2024 - 03 - 25
6
2024 - 03 - 22
7
2024 - 03 - 21
10
2024 - 03 - 15
5
2024 - 03 - 14
10
2024 - 03 - 13
7
2024 - 03 - 12
7
2024 - 03 - 11
12
2024 - 03 - 08
9
2024 - 03 - 07
8
2024 - 03 - 06
5
2024 - 03 - 05
11
2024 - 03 - 04
7
2024 - 02 - 29
5
2024 - 02 - 28
7
2024 - 02 - 27
8
2024 - 02 - 23
7
2024 - 02 - 22
6
2024 - 02 - 21
5
2024 - 02 - 19
4
2024 - 02 - 16
4
2024 - 02 - 15
8
2024 - 02 - 14
5
2024 - 02 - 13
5
2024 - 02 - 12
8
2024 - 02 - 09
5
2024 - 02 - 08
4
2024 - 02 - 07
5
2024 - 02 - 02
10
2024 - 02 - 01
10
2024 - 01 - 31
4
2024 - 01 - 30
6
2024 - 01 - 29
6
2024 - 01 - 26
8
2024 - 01 - 25
6
2024 - 01 - 24
5
2024 - 01 - 23
8
2024 - 01 - 22
6
2024 - 01 - 17
12
2024 - 01 - 16
6
2024 - 01 - 15
4
2024 - 01 - 11
6
2024 - 01 - 10
5
2024 - 01 - 09
11
2024 - 01 - 08
9
2024 - 01 - 04
6
2024 - 01 - 03
6
Sector
Commercial services
4
Communications
3
Consumer durables
1
Consumer non-durables
10
Consumer services
2
Distribution services
2
Electronic technology
1
Energy minerals
1
Finance
4
Health services
1
Health technology
478
Information
1
Manufacturing
35
Mining, quarrying, and oil and gas extraction
2
N/a
19
Non-energy minerals
2
Process industries
4
Producer manufacturing
1
Professional, scientific, and technical services
4
Retail trade
1
Technology services
39
Transportation
1
Transportation and warehousing
1
Tags
Advanced
6
America
12
Antibody
7
Approval
8
Approved
9
Astrazeneca
8
Biopharma
39
Biotechnology
26
Blood
6
Business
13
Cancer
29
Ceo
6
Conference
9
Disease
14
Drug
30
Dupixent
12
Earnings
9
Events
10
Fda
52
Fda-approvals
16
Financial
29
First
24
For
13
Genetown
7
Global
63
Growth
39
Health
7
Key
17
Layoffs
27
Market
113
Medical
8
Meeting
9
Merck
6
Million
9
N/a
278
News
15
People
11
Pharma
17
Pharmaceutical
21
Pharmaceuticals
11
Pipeline
10
Potential
9
Preclinical
6
Reach
14
Regulatory
18
Report
56
Research
30
Results
30
Review
8
Sales
7
Sanofi
28
Set
10
Study
10
Therapeutics
54
Therapy
9
Treatment
42
Trends
6
Trial
12
Update
13
Year
25
Entities
2seventy bio, inc.
2
Abbott laboratories
72
Abbvie inc.
31
Akebia therapeutics, inc.
2
Alnylam pharmaceuticals, inc.
4
Alphabet inc.
36
Amarin corporation plc
35
Amgen inc.
21
Anika therapeutics inc.
2
Applied genetic technologies corporation
4
Astellas pharma inc
16
Astrazeneca plc
27
Baxter international inc.
5
Biogen inc.
8
Biomarin pharmaceutical inc.
3
Biontech se
2
Brainstorm cell therapeutics inc.
2
Bristol-myers squibb company
11
Calliditas therapeutics ab
2
Csl ltd
2
Curative biotechnology inc
3
Curevac n.v.
2
Denali therapeutics inc.
3
Elanco animal health incorporated
2
Eli lilly and company
34
Galapagos nv
36
Gilead sciences, inc.
5
Glaxosmithkline plc
28
Icon plc
4
Igm biosciences, inc.
6
Incyte corporation
8
Inhibrx, inc.
6
Innate pharma s.a.
13
Innate pharma sa
12
Johnson & johnson
137
Kellogg company
3
Kymera therapeutics, inc.
4
Medies
8
Moderna, inc.
3
Moonlake immunotherapeutics - class a
5
Morphosys ag
35
Nektar therapeutics
36
Novartis ag
38
Novo nordisk a/s
3
Nurix therapeutics, inc.
4
Oncocyte corporation
35
Orange
3
Perrigo company
49
Ptc therapeutics, inc.
35
Rallybio corp
35
Reckitt benckiser group plc
5
Regeneron pharmaceuticals, inc.
19
Sanofi
478
Takeda pharmaceutical company limited
6
Teva pharmaceutical industries ltd
23
Therapeuticsmd, inc.
35
Thermo fisher scientific inc
7
Vaxart, inc.
35
Vertex pharmaceuticals incorporated
4
Viatris inc.
12
Symbols
AAPL
87
ABB
109
ABBNY
109
ABBV
106
ABLZF
109
ABT
213
ADM
81
AMLX
77
AMSIY
82
AMSYF
82
ARCXF
82
ARVL
448
ASRT
74
BNPQF
123
BNPQY
123
BNTX
83
BTI
76
CMI
117
CPT
249
CSCO
84
DADA
84
EAF
77
ERIC
148
FLNT
88
FNCTF
937
GOOG
163
GOOGL
163
HON
154
INMD
85
IRTC
80
JNJ
526
KGS
261
LLY
131
LTRX
75
LTUM
84
MBLY
94
MDT
89
MEDE
139
MS
418
MT
82
NOK
86
NOKBF
101
NVS
113
NVSEF
110
NYCB
88
PB
278
PPRUF
114
PPRUY
114
RILY
83
SAP
91
SAPGF
91
SIF
106
SNOW
75
SNY
478
SNYNF
478
STLA
80
TMO
173
UNTY
99
VZ
133
XYF
99
Exchanges
Amex
35
Nasdaq
478
Nyse
219
Crawled Date
2024 - 04 - 24
9
2024 - 04 - 23
5
2024 - 04 - 22
6
2024 - 04 - 19
6
2024 - 04 - 17
6
2024 - 04 - 10
7
2024 - 04 - 09
5
2024 - 04 - 08
5
2024 - 04 - 05
7
2024 - 04 - 03
5
2024 - 04 - 02
5
2024 - 03 - 28
5
2024 - 03 - 27
10
2024 - 03 - 25
5
2024 - 03 - 22
7
2024 - 03 - 21
10
2024 - 03 - 19
5
2024 - 03 - 15
5
2024 - 03 - 14
10
2024 - 03 - 13
8
2024 - 03 - 12
6
2024 - 03 - 11
12
2024 - 03 - 08
10
2024 - 03 - 07
7
2024 - 03 - 06
5
2024 - 03 - 05
11
2024 - 03 - 04
7
2024 - 02 - 29
5
2024 - 02 - 28
7
2024 - 02 - 27
8
2024 - 02 - 23
7
2024 - 02 - 22
6
2024 - 02 - 21
5
2024 - 02 - 20
5
2024 - 02 - 15
8
2024 - 02 - 14
6
2024 - 02 - 13
4
2024 - 02 - 12
8
2024 - 02 - 09
4
2024 - 02 - 08
4
2024 - 02 - 07
6
2024 - 02 - 02
10
2024 - 02 - 01
9
2024 - 01 - 31
4
2024 - 01 - 30
6
2024 - 01 - 29
6
2024 - 01 - 26
7
2024 - 01 - 25
6
2024 - 01 - 24
5
2024 - 01 - 23
8
2024 - 01 - 22
6
2024 - 01 - 17
12
2024 - 01 - 16
6
2024 - 01 - 15
4
2024 - 01 - 11
6
2024 - 01 - 10
5
2024 - 01 - 09
11
2024 - 01 - 08
9
2024 - 01 - 04
6
2024 - 01 - 03
6
Crawled Time
00:00
23
00:20
3
01:00
7
02:00
13
03:00
9
04:00
8
04:20
4
05:00
17
06:00
15
07:00
16
08:00
9
09:00
20
10:00
4
11:00
15
12:00
29
12:30
11
13:00
27
13:30
17
14:00
16
14:30
23
15:00
29
15:30
21
16:00
18
16:20
3
17:00
36
18:00
21
19:00
10
20:00
13
20:20
1
21:00
8
22:00
16
23:00
16
Source
clarivate.com
1
spacfeed.com
2
www.biospace.com
200
www.globenewswire.com
96
www.mpmcapital.com
1
www.prnewswire.com
177
www.pzena.com
1
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
published :
This year
symbols :
SNY
save search
Sobi Q1 2024 report: Strong sales reflecting the strength of the portfolio
Published:
2024-04-25
(Crawled : 08:00)
- biospace.com/
SNYNF
|
News
|
$94.0
-0.27%
-2.18%
310
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.61
-2.27%
-2.21%
1.6M
|
Health Technology
|
Email alert
Add to watchlist
sales
Press Release: Sanofi Q1: robust 7% sales growth driven by launches, underpins full-year guidance
Published:
2024-04-25
(Crawled : 06:00)
- globenewswire.com
SNYNF
|
News
|
$94.0
-0.27%
-2.18%
310
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.61
-2.27%
-2.21%
1.6M
|
Health Technology
|
Email alert
Add to watchlist
sales
sanofi
growth
Dassault Systèmes Reports Solid First Quarter Results And Reaffirms Full-Year Objectives
Published:
2024-04-25
(Crawled : 05:00)
- globenewswire.com
SNYNF
|
News
|
$94.0
-0.27%
-2.18%
310
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.61
-2.27%
-2.21%
1.6M
|
Health Technology
|
Email alert
Add to watchlist
first
results
Innovent to Present Clinical Data of Multiple Novel Molecules at the 2024 ASCO Annual Meeting
Published:
2024-04-25
(Crawled : 02:00)
- prnewswire.com
SNY
|
News
|
$46.61
-2.27%
-2.21%
1.6M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$94.0
-0.27%
-2.18%
310
|
Health Technology
|
Email alert
Add to watchlist
asco
meeting
First Approval for Rare Pediatric Cancer; New OTC Opioid Overdose Option
Published:
2024-04-24
(Crawled : 16:00)
- biospace.com/
SNYNF
|
News
|
$94.0
-0.27%
-2.18%
310
|
Health Technology
|
-0.27%
|
O:
0.8%
H:
0.0%
C:
-1.05%
PRGO
|
$31.23
2.43%
0.0%
960K
|
Health Technology
|
2.43%
|
O:
0.1%
H:
0.0%
C:
0.0%
JNJ
|
News
|
$148.53
-0.69%
0.18%
7.5M
|
Health Technology
|
-1.02%
|
O:
-1.02%
H:
0.0%
C:
0.0%
ABT
|
News
|
$106.89
-0.65%
0.07%
4.2M
|
Health Technology
|
-0.65%
|
O:
-0.82%
H:
0.37%
C:
0.17%
XOMA
|
$25.64
-1.73%
-3.9%
8.2K
|
Health Technology
|
-1.72%
|
O:
0.19%
H:
0.0%
C:
-1.91%
SNY
|
News
|
$46.61
-2.27%
-2.21%
1.6M
|
Health Technology
|
0.82%
|
O:
0.82%
H:
0.0%
C:
0.0%
rare
first
opioid
approval
for
CureVac Appoints Thaminda Ramanayake as New Chief Business Officer
Published:
2024-04-24
(Crawled : 15:00)
- biospace.com/
SNYNF
|
News
|
$94.0
-0.27%
-2.18%
310
|
Health Technology
|
-0.27%
|
O:
0.8%
H:
0.0%
C:
-1.05%
JNJ
|
News
|
$148.53
-0.69%
0.18%
7.5M
|
Health Technology
|
-1.02%
|
O:
-1.02%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.61
-2.27%
-2.21%
1.6M
|
Health Technology
|
0.82%
|
O:
0.82%
H:
0.0%
C:
0.0%
CVAC
|
$2.51
-3.46%
-3.59%
1.1M
|
Health Technology
|
-3.46%
|
O:
-4.62%
H:
4.44%
C:
1.21%
business
Lantern Pharma Launches “Webinar Wednesdays” Featuring World-Class Physician Scientists & Key Opinion Leaders Discussing Critical Areas of Oncology Drug Development
Published:
2024-04-24
(Crawled : 14:00)
- biospace.com/
SNYNF
|
News
|
$94.0
-0.27%
-2.18%
310
|
Health Technology
|
-0.27%
|
O:
0.8%
H:
0.0%
C:
-1.05%
SNY
|
News
|
$46.61
-2.27%
-2.21%
1.6M
|
Health Technology
|
0.82%
|
O:
0.82%
H:
0.0%
C:
0.0%
LTRN
|
News
|
$5.38
-6.76%
-6.07%
98K
|
Health Technology
|
-6.76%
|
O:
1.21%
H:
2.91%
C:
-7.88%
pharma
drug
key
leaders
development
Regeneron to Showcase Progress in Advancing Novel Investigational Treatment Approaches for a Broad Range of Solid Tumors and Blood Cancers at ASCO
Published:
2024-04-24
(Crawled : 14:00)
- globenewswire.com
SNYNF
|
News
|
$94.0
-0.27%
-2.18%
310
|
Health Technology
|
-0.27%
|
O:
0.8%
H:
0.0%
C:
-1.05%
SNY
|
News
|
$46.61
-2.27%
-2.21%
1.6M
|
Health Technology
|
0.82%
|
O:
0.82%
H:
0.0%
C:
0.0%
REGN
|
News
|
$906.54
-0.09%
-0.08%
280K
|
Health Technology
|
-0.09%
|
O:
-0.05%
H:
0.97%
C:
-0.04%
asco
tumors
treatment
blood
for
Sanofi Layoffs, CAR-T Warnings and a New GLP-1 Player
Published:
2024-04-24
(Crawled : 13:00)
- biospace.com/
SNYNF
|
News
|
$94.0
-0.27%
-2.18%
310
|
Health Technology
|
-0.27%
|
O:
0.8%
H:
0.0%
C:
-1.05%
SNY
|
News
|
$46.61
-2.27%
-2.21%
1.6M
|
Health Technology
|
0.82%
|
O:
0.82%
H:
0.0%
C:
0.0%
car-t
sanofi
CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update
Published:
2024-04-24
(Crawled : 13:00)
- biospace.com/
SNYNF
|
News
|
$94.0
-0.27%
-2.18%
310
|
Health Technology
|
-0.27%
|
O:
0.8%
H:
0.0%
C:
-1.05%
SNY
|
News
|
$46.61
-2.27%
-2.21%
1.6M
|
Health Technology
|
0.82%
|
O:
0.82%
H:
0.0%
C:
0.0%
CVAC
|
$2.51
-3.46%
-3.59%
1.1M
|
Health Technology
|
-3.46%
|
O:
-4.62%
H:
4.44%
C:
1.21%
BNTX
|
News
|
$88.09
-0.45%
-0.35%
230K
|
Health Technology
|
-0.45%
|
O:
0.11%
H:
0.97%
C:
-0.56%
business
update
for
financial
results
Biopharma Layoff Tracker 2024: Tessera, BMS, Pfizer and More Cut Staff
Published:
2024-04-24
(Crawled : 12:00)
- biospace.com/
SNYNF
|
News
|
$94.0
-0.27%
-2.18%
310
|
Health Technology
|
-0.27%
|
O:
0.8%
H:
0.0%
C:
-1.05%
RLYB
|
News
|
$1.58
-9.2%
-9.43%
250K
|
|
-12.47%
|
O:
-3.05%
H:
0.0%
C:
-9.71%
JNJ
|
News
|
$148.53
-0.69%
0.18%
7.5M
|
Health Technology
|
-1.02%
|
O:
-1.02%
H:
0.0%
C:
0.0%
VXRT
|
News
|
$0.7097
-4.79%
-5.72%
1.4M
|
Health Technology
|
-8.39%
|
O:
-1.94%
H:
0.0%
C:
-6.58%
TXMD
|
News
|
$1.92
2.13%
-0.27%
15K
|
Health Technology
|
2.13%
|
O:
0.53%
H:
2.12%
C:
1.59%
SNY
|
News
|
$46.61
-2.27%
-2.21%
1.6M
|
Health Technology
|
0.82%
|
O:
0.82%
H:
0.0%
C:
0.0%
PTCT
|
News
S
|
$25.21
-0.79%
-0.87%
560K
|
Health Technology
|
-2.95%
|
O:
-0.71%
H:
0.81%
C:
-2.25%
NKTR
|
News
|
$1.38
-2.82%
-2.16%
960K
|
Health Technology
|
-0.36%
|
O:
-1.08%
H:
3.65%
C:
0.73%
MOR
|
News
|
$18.05
0.06%
0.17%
130K
|
Health Technology
|
0.06%
|
O:
0.0%
H:
0.28%
C:
0.06%
GLPG
|
News
|
$28.77
-2.31%
-2.33%
130K
|
Health Technology
|
-1.41%
|
O:
0.48%
H:
0.17%
C:
-1.88%
AMRN
|
News
|
$0.8786
-0.53%
0.12%
640K
|
Health Technology
|
0.57%
|
O:
0.57%
H:
1.14%
C:
0.0%
GOOGL
|
News
4
|
$159.13
0.55%
0.58%
18M
|
Technology Services
|
1.34%
|
O:
0.29%
H:
1.31%
C:
1.04%
GOOG
|
News
4
|
$161.1
0.74%
0.7%
16M
|
Technology Services
|
1.58%
|
O:
0.32%
H:
1.45%
C:
1.26%
OCX
|
News
|
$2.46
0.2%
-6.74%
40K
|
Health Technology
|
0.0%
|
O:
2.03%
H:
0.0%
C:
-1.99%
biopharma
Biopharma Layoff Tracker 2024: Tessera, BenevolentAI, Pfizer and More Cut Staff
Published:
2024-04-24
(Crawled : 05:00)
- biospace.com/
SNYNF
|
News
|
$94.0
-0.27%
-2.18%
310
|
Health Technology
|
-0.27%
|
O:
0.8%
H:
0.0%
C:
-1.05%
RLYB
|
News
|
$1.58
-9.2%
-9.43%
250K
|
|
-12.47%
|
O:
-3.05%
H:
0.0%
C:
-9.71%
JNJ
|
News
|
$148.53
-0.69%
0.18%
7.5M
|
Health Technology
|
-1.02%
|
O:
-1.02%
H:
0.0%
C:
0.0%
VXRT
|
News
|
$0.7097
-4.79%
-5.72%
1.4M
|
Health Technology
|
-8.39%
|
O:
-1.94%
H:
0.0%
C:
-6.58%
TXMD
|
News
|
$1.92
2.13%
-0.27%
15K
|
Health Technology
|
2.13%
|
O:
0.53%
H:
2.12%
C:
1.59%
SNY
|
News
|
$46.61
-2.27%
-2.21%
1.6M
|
Health Technology
|
0.82%
|
O:
0.82%
H:
0.0%
C:
0.0%
PTCT
|
News
S
|
$25.21
-0.79%
-0.87%
560K
|
Health Technology
|
-2.95%
|
O:
-0.71%
H:
0.81%
C:
-2.25%
NKTR
|
News
|
$1.38
-2.82%
-2.16%
960K
|
Health Technology
|
-0.36%
|
O:
-1.08%
H:
3.65%
C:
0.73%
MOR
|
News
|
$18.05
0.06%
0.17%
130K
|
Health Technology
|
0.06%
|
O:
0.0%
H:
0.28%
C:
0.06%
GLPG
|
News
|
$28.77
-2.31%
-2.33%
130K
|
Health Technology
|
-1.41%
|
O:
0.48%
H:
0.17%
C:
-1.88%
AMRN
|
News
|
$0.8786
-0.53%
0.12%
640K
|
Health Technology
|
0.57%
|
O:
0.57%
H:
1.14%
C:
0.0%
GOOGL
|
News
4
|
$159.13
0.55%
0.58%
18M
|
Technology Services
|
1.34%
|
O:
0.29%
H:
1.31%
C:
1.04%
GOOG
|
News
4
|
$161.1
0.74%
0.7%
16M
|
Technology Services
|
1.58%
|
O:
0.32%
H:
1.45%
C:
1.26%
OCX
|
News
|
$2.46
0.2%
-6.74%
40K
|
Health Technology
|
0.0%
|
O:
2.03%
H:
0.0%
C:
-1.99%
biopharma
Curio Digital Therapeutics Inc. Announces the U.S. Food and Drug Administration (FDA) Clearance of MamaLift Plus™, the First Prescription Digital Therapeutic Authorized for the Treatment of Postpartum Depression (PPD)
Published:
2024-04-23
(Crawled : 00:00)
- biospace.com/
SNY
|
News
|
$46.61
-2.27%
-2.21%
1.6M
|
Health Technology
|
2.53%
|
O:
1.7%
H:
0.0%
C:
0.0%
first
drug
authorized
food
depression
treatment
clearance
for
therapeutics
Biopharma Layoff Tracker 2024: BenevolentAI, Pfizer, Sanofi and More Cut Staff
Published:
2024-04-23
(Crawled : 14:30)
- biospace.com/
RLYB
|
News
|
$1.58
-9.2%
-9.43%
250K
|
|
-10.73%
|
O:
1.98%
H:
0.0%
C:
0.0%
JNJ
|
News
|
$148.53
-0.69%
0.18%
7.5M
|
Health Technology
|
-0.13%
|
O:
0.89%
H:
0.0%
C:
0.0%
VXRT
|
News
|
$0.7097
-4.79%
-5.72%
1.4M
|
Health Technology
|
-6.58%
|
O:
1.97%
H:
0.0%
C:
0.0%
TXMD
|
News
|
$1.92
2.13%
-0.27%
15K
|
Health Technology
|
2.13%
|
O:
-0.53%
H:
1.07%
C:
0.53%
SNY
|
News
|
$46.61
-2.27%
-2.21%
1.6M
|
Health Technology
|
2.53%
|
O:
1.7%
H:
0.0%
C:
0.0%
PTCT
|
News
S
|
$25.21
-0.79%
-0.87%
560K
|
Health Technology
|
-2.93%
|
O:
0.02%
H:
0.0%
C:
0.0%
NKTR
|
News
|
$1.38
-2.82%
-2.16%
960K
|
Health Technology
|
1.47%
|
O:
1.84%
H:
0.0%
C:
0.0%
MOR
|
News
|
$18.05
0.06%
0.17%
130K
|
Health Technology
|
0.45%
|
O:
0.39%
H:
0.0%
C:
0.0%
GLPG
|
News
|
$28.77
-2.31%
-2.33%
130K
|
Health Technology
|
-1.03%
|
O:
0.38%
H:
0.0%
C:
0.0%
AMRN
|
News
|
$0.8786
-0.53%
0.12%
640K
|
Health Technology
|
1.15%
|
O:
0.57%
H:
0.0%
C:
0.0%
GOOGL
|
News
4
|
$159.13
0.55%
0.58%
18M
|
Technology Services
|
1.82%
|
O:
0.48%
H:
0.0%
C:
0.0%
GOOG
|
News
4
|
$161.1
0.74%
0.7%
16M
|
Technology Services
|
1.99%
|
O:
0.41%
H:
0.0%
C:
0.0%
OCX
|
News
|
$2.46
0.2%
-6.74%
40K
|
Health Technology
|
-1.99%
|
O:
-1.99%
H:
0.0%
C:
0.0%
biopharma
sanofi
Response Pharmaceuticals’ Drug Candidate for the Treatment of Antipsychotic-Induced Weight Gain (AIWG) Achieves Primary Endpoint in Phase 1b Clinical Trial
Published:
2024-04-23
(Crawled : 14:30)
- biospace.com/
SNY
|
News
|
$46.61
-2.27%
-2.21%
1.6M
|
Health Technology
|
2.53%
|
O:
1.7%
H:
0.0%
C:
0.0%
drug
candidate
treatment
for
trial
response
FDA Rejects Abeona’s Gene Therapy, Approves ImmunityBio’s Bladder Cancer Treatment
Published:
2024-04-23
(Crawled : 13:30)
- biospace.com/
PRGO
|
$31.23
2.43%
0.0%
960K
|
Health Technology
|
3.89%
|
O:
0.13%
H:
1.89%
C:
1.3%
JNJ
|
News
|
$148.53
-0.69%
0.18%
7.5M
|
Health Technology
|
-0.13%
|
O:
0.89%
H:
0.0%
C:
0.0%
ABT
|
News
|
$106.89
-0.65%
0.07%
4.2M
|
Health Technology
|
-0.17%
|
O:
0.56%
H:
0.41%
C:
-0.07%
SNY
|
News
|
$46.61
-2.27%
-2.21%
1.6M
|
Health Technology
|
2.53%
|
O:
1.7%
H:
0.0%
C:
0.0%
fda
bladder
cancer
treatment
Sanofi’s $3.7B Principia Buy Starts to Pay Off with Phase III Rilzabrutinib Win
Published:
2024-04-23
(Crawled : 13:30)
- biospace.com/
SNY
|
News
|
$46.61
-2.27%
-2.21%
1.6M
|
Health Technology
|
2.53%
|
O:
1.7%
H:
0.0%
C:
0.0%
Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia
Published:
2024-04-23
(Crawled : 05:00)
- globenewswire.com
SNY
|
News
|
$46.61
-2.27%
-2.21%
1.6M
|
Health Technology
|
2.53%
|
O:
1.7%
H:
0.0%
C:
0.0%
study
Over-The-Counter Drug Market size is set to grow by USD 58.54 billion from 2023-2027, Abbott Laboratories, Achelios Therapeutics Inc. and AstraZeneca Plc, and more to emerge as Some of the Key Vendors, Technavio
Published:
2024-04-22
(Crawled : 22:00)
- prnewswire.com
RBGPF
|
News
|
$53.94
3.53%
6.46%
3.4K
|
Consumer Non-Durables
|
3.61%
|
O:
0.98%
H:
5.46%
C:
-0.89%
GLAXF
|
News
|
$19.54
-3.77%
-14.18%
170
|
Health Technology
|
-2.22%
|
O:
-3.15%
H:
0.0%
C:
-0.61%
AZNCF
|
News
|
$135.35
-3.53%
-4.19%
400
|
Health Technology
|
-2.44%
|
O:
0.96%
H:
2.38%
C:
0.17%
NVSEF
|
News
|
$96.0
0.94%
6.88%
0
|
Health Technology
|
0.94%
|
O:
1.69%
H:
0.02%
C:
-0.74%
RBGLY
|
News
|
$10.98
2.0%
-2.05%
860K
|
Manufacturing
|
3.68%
|
O:
-0.28%
H:
2.18%
C:
1.99%
NVS
|
News
|
$98.35
1.1%
0.69%
2.1M
|
Health Technology
|
3.78%
|
O:
4.32%
H:
0.0%
C:
0.0%
GSK
|
News
|
$40.86
-0.92%
1.25%
1.6M
|
Health Technology
|
0.67%
|
O:
0.17%
H:
1.48%
C:
1.43%
ABT
|
News
|
$106.89
-0.65%
0.07%
4.2M
|
Health Technology
|
-0.17%
|
O:
0.56%
H:
0.41%
C:
-0.07%
SNY
|
News
|
$46.61
-2.27%
-2.21%
1.6M
|
Health Technology
|
2.53%
|
O:
1.7%
H:
0.0%
C:
0.0%
AZN
|
News
|
$71.2
0.49%
0.46%
5.4M
|
Health Technology
|
1.53%
|
O:
0.4%
H:
0.0%
C:
0.0%
drug
astrazeneca
set
key
therapeutics
market
Regeneron to Highlight Advances in Genetic Medicine Research at American Society of Gene and Cell Therapy (ASGCT)
Published:
2024-04-22
(Crawled : 22:00)
- globenewswire.com
SNY
|
News
|
$46.61
-2.27%
-2.21%
1.6M
|
Health Technology
|
2.53%
|
O:
1.7%
H:
0.0%
C:
0.0%
REGN
|
News
|
$906.54
-0.09%
-0.08%
280K
|
Health Technology
|
0.61%
|
O:
0.51%
H:
0.78%
C:
0.18%
genetic
cell
research
therapy
← Previous
1
2
3
4
5
6
7
8
9
…
23
24
Next →
Gainers vs Losers
62%
38%
Top 10 Gainers
CSSE
4
|
$0.4253
179.25%
64.77%
210M
|
Consumer Services
BOF
|
$2.08
77.78%
41.21%
110M
|
ILAG
|
$0.54
12.27%
40.62%
3.7M
|
LICN
|
$0.999
78.39%
40.49%
15M
|
AMST
|
$3.4
70.0%
39.58%
70M
|
Technology Services
MTC
|
$3.6
60.71%
38.04%
9.1M
|
Technology Services
WIMI
|
$1.15
58.53%
36.92%
19M
|
Technology Services
AIH
|
$0.458
14.5%
30.92%
91K
|
Health Services
WHLM
|
$6.25
35.87%
28.46%
700K
|
Commercial Services
MULN
|
News
|
$3.77
38.1%
27.78%
13M
|
Information
Your saved searches
Save your searches and get alerts when important news are released.